Skip to main content
. Author manuscript; available in PMC: 2022 Oct 31.
Published in final edited form as: Am J Gastroenterol. 2020 Mar;115(3):398–405. doi: 10.14309/ajg.0000000000000492

Figure 2.

Figure 2.

Kaplan-Meier curves illustrating the differences in survival in groups stratified by “low” (≤102 mg/dL) and “high” (>102 mg/dL) serum transferrin levels. The cutoff value for transferrin was determined through the application of the Youden index to the ROC curve for serum transferrin in relation to 28-day mortality. Patients with “low” serum transferrin displayed significantly higher mortality at both 28 (24.0% vs 7.6%, P < 0.0001, log rank test) and 90 days (32.9% vs 17.4%, P < 0.0001, log rank test).